Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: Results from a Register Study

Acta Derm Venereol. 2023 Aug 16:103:adv7138. doi: 10.2340/actadv.v103.7138.

Authors

Axel Svedbom¹, Mona Ståhle²

Affiliations

¹ Division of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. axel.svedbom@ki.se.
² Division of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

No abstract available

MeSH terms

Depression* / diagnosis
Depression* / drug therapy
Humans
Interleukin-17
Interleukin-23
Psoriasis* / complications
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Quality of Life
Severity of Illness Index

Substances

Interleukin-17
Interleukin-23